Biological activity of dihydropyrimidinone (DHPM) derivatives: A systematic review.

Eur J Med Chem

Department of Pharmaceutical Sciences, Health Sciences School, University of Brasilia, Brazil. Electronic address:

Published: January 2018

Dihydropyrimidinones are heterocycles with a pyrimidine moiety in the ring nucleus, which, in recent decades, have aroused interest in medicinal chemistry due to alleged versatile biological activity. In this systematic review, we describe the currently published activities of dihydropyrimidinone derivatives. Between 1990 and December 31st, 2016, 115 articles outlined biological activities or toxicity of DHPM derivatives, 12 of those involved in vivo experiments. The main activities associated with this class of compounds are antitumoral (43 articles), anti-inflammatory (12 articles), antibacterial (20 articles) and calcium channel antagonism/inhibition (14 articles). Antitumoral activity is the main biological property evaluated, since the main representative compound of this class (monastrol) is a known Eg5 kinesin inhibitor. This review depicts a variety of other pharmacological activities associated with DHPM derivatives, but the main findings are essentially in vitro characteristics of the substances. This review presents the current state of the art of DHPM biological activities and demonstrates that there is still a need for further in vivo studies to better delineate the pharmacological potential of this class of substances.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmech.2017.10.073DOI Listing

Publication Analysis

Top Keywords

dhpm derivatives
12
biological activity
8
systematic review
8
biological activities
8
activities associated
8
biological
5
activities
5
articles
5
activity dihydropyrimidinone
4
dhpm
4

Similar Publications

Article Synopsis
  • - A series of dihydropyrimidine compounds were created as inhibitors of tyrosine kinases through a one-pot Biginelli reaction, yielding a variety of 1,4-DHPM hybrids by alkylating with different chloroacetylamine derivatives.
  • - These synthesized compounds were tested for their ability to inhibit cancer cell growth in different cell lines (HCT-116, PC-3, MCF-7) and showed that compounds 8h and 8i were the most effective, with low concentrations needed to inhibit cancer cells while being more selective towards normal cells.
  • - Further analysis revealed that compound 8h was particularly potent in inhibiting key kinases (EGFR and Trk
View Article and Find Full Text PDF

Cucumbers produce by-products such as cucumber pomace during processing and most of them are discarded without being utilized. To effectively utilize the waste, cucumber pomace is used to extract both insoluble and soluble dietary fibers (DFs) using compound enzyme method (ME), High pressure processing assisted ME (HPP-ME), and dynamic high-pressure microfluidization-assisted ME (DHPM-ME). The results showed that DHPM-ME improved the extraction rate of soluble DFs most effectively, increasing it from 1.

View Article and Find Full Text PDF

Owing to the massive importance of dihydropyrimidine (DHPMs) scaffolds in the pharmaceutical industry and other areas, we developed an effective and sustainable one-pot reaction protocol for the synthesis of (/)-2-thioxo-DHPM-5-carboxanilides the Biginelli-type cyclo-condensation reaction of aryl aldehydes, thiourea and various acetoacetanilide derivatives in ethanol at 100 °C. In this protocol, taurine was used as a green and reusable bio-organic catalyst. Twenty-three novel derivatives of (/)-TDHPM-5-carboxanilides and their structures were confirmed by various spectroscopy techniques.

View Article and Find Full Text PDF

Cyclooxygenase-2 (COX-2) is an enzyme involved in inflammation. The overexpression of COX-2 causes chronic inflammation, which can be prevented by COX-2 inhibitors. Generally, COX-2 inhibitors possess a carboxyl group and an aromatic ring in their molecular structure.

View Article and Find Full Text PDF

Dihydropyrimidine derivatives as MDM2 inhibitors.

Chem Biol Drug Des

January 2024

Department of Medicinal Chemistry, School of Pharmacy and Pharmaceutical Science, Isfahan University of Medical Science, Isfahan, Iran.

One of the chief pathways to regulate p53 levels is MDM2 protein, which negatively controls p53 by direct inhibition. Many cancers overproduce MDM2 protein to interrupt p53 functions. Therefore, impeding MDM2's binding to p53 can reactivate p53 in tumor cells may suggest an effective approach for tumor therapy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!